Literature DB >> 18519042

Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.

Catherine Manser1, Alison Stevenson1, Steven Banner1, Jennifer Davies1, Elizabeth L Tudor1, Yoshitaka Ono2, P Nigel Leigh1, Declan M McLoughlin1, Christopher E Shaw1, Christopher C J Miller1.   

Abstract

Neurofilaments are synthesised in neuronal cell bodies and then transported through axons. Damage to neurofilament transport is seen in amyotrophic lateral sclerosis (ALS). Here, we show that PKN1, a neurofilament head-rod domain kinase is cleaved and activated in SOD1G93A transgenic mice that are a model of ALS. Moreover, we demonstrate that glutamate, a proposed toxic mechanism in ALS leads to caspase cleavage and disruption of PKN1 in neurons. Finally, we demonstrate that a cleaved form of PKN1 but not wild-type PKN1 disrupts neurofilament organisation and axonal transport. Thus, deregulation of PKN1 may contribute to the pathogenic process in ALS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519042      PMCID: PMC4516414          DOI: 10.1016/j.febslet.2008.05.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Hyperosmotic-induced protein kinase N 1 activation in a vesicular compartment is dependent upon Rac1 and 3-phosphoinositide-dependent kinase 1.

Authors:  Neil E Torbett; Adele Casamassima; Peter J Parker
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

2.  Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.

Authors:  T L Williamson; D W Cleveland
Journal:  Nat Neurosci       Date:  1999-01       Impact factor: 24.884

3.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

4.  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF.

Authors:  San Pun; Alexandre Ferrão Santos; Smita Saxena; Lan Xu; Pico Caroni
Journal:  Nat Neurosci       Date:  2006-02-12       Impact factor: 24.884

5.  The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures.

Authors:  D R Davis; J P Brion; A M Couck; J M Gallo; D P Hanger; K Ladhani; C Lewis; C C Miller; T Rupniak; C Smith
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

6.  Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3.

Authors:  J Brownlees; A Yates; N P Bajaj; D Davis; B H Anderton; P N Leigh; C E Shaw; C C Miller
Journal:  J Cell Sci       Date:  2000-02       Impact factor: 5.285

7.  Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.

Authors:  B Zhang; P Tu; F Abtahian; J Q Trojanowski; V M Lee
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

8.  Glutamate slows axonal transport of neurofilaments in transfected neurons.

Authors:  S Ackerley; A J Grierson; J Brownlees; P Thornhill; B H Anderton; P N Leigh; C E Shaw; C C Miller
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

9.  Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments.

Authors:  G Y Ching; R K Liem
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

10.  Neurofilaments are obligate heteropolymers in vivo.

Authors:  M K Lee; Z Xu; P C Wong; D W Cleveland
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  17 in total

1.  Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions.

Authors:  Maria C Bonaglia; Susan Marelli; Francesca Novara; Simona Commodaro; Renato Borgatti; Grazia Minardo; Luigi Memo; Elisabeth Mangold; Silvana Beri; Claudio Zucca; Daniele Brambilla; Massimo Molteni; Roberto Giorda; Ruthild G Weber; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 2.  Neurofilaments at a glance.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  J Cell Sci       Date:  2012-07-15       Impact factor: 5.285

3.  Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Authors:  Hiromitsu Takagi; Chiao-Po Hsu; Katsuya Kajimoto; Dan Shao; Yanfei Yang; Yasuhiro Maejima; Peiyong Zhai; Ghassan Yehia; Chikaomi Yamada; Daniela Zablocki; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

4.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

Review 5.  Neurofilaments: neurobiological foundations for biomarker applications.

Authors:  Arie R Gafson; Nicolas R Barthélemy; Pascale Bomont; Roxana O Carare; Heather D Durham; Jean-Pierre Julien; Jens Kuhle; David Leppert; Ralph A Nixon; Roy O Weller; Henrik Zetterberg; Paul M Matthews
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

6.  Co-clustering phenome-genome for phenotype classification and disease gene discovery.

Authors:  TaeHyun Hwang; Gowtham Atluri; MaoQiang Xie; Sanjoy Dey; Changjin Hong; Vipin Kumar; Rui Kuang
Journal:  Nucleic Acids Res       Date:  2012-06-26       Impact factor: 16.971

7.  Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells.

Authors:  Richard G James; Katherine A Bosch; Rima M Kulikauskas; Peitzu T Yang; Nick C Robin; Rachel A Toroni; Travis L Biechele; Jason D Berndt; Priska D von Haller; Jimmy K Eng; Alejandro Wolf-Yadlin; Andy J Chien; Randall T Moon
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

8.  Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons.

Authors:  Bettina Thauerer; Stephanie Zur Nedden; Gabriele Baier-Bitterlich
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

Review 9.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

10.  Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration.

Authors:  J-Y Hwang; J Lee; C-K Oh; H W Kang; I-Y Hwang; J W Um; H C Park; S Kim; J-H Shin; W-Y Park; R B Darnell; H-D Um; K C Chung; K Kim; Y J Oh
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.